Jane E. Mackie

3.4k total citations · 1 hit paper
13 papers, 2.8k citations indexed

About

Jane E. Mackie is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Jane E. Mackie has authored 13 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Pharmacology. Recurrent topics in Jane E. Mackie's work include Porphyrin Metabolism and Disorders (6 papers), Heme Oxygenase-1 and Carbon Monoxide (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). Jane E. Mackie is often cited by papers focused on Porphyrin Metabolism and Disorders (6 papers), Heme Oxygenase-1 and Carbon Monoxide (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). Jane E. Mackie collaborates with scholars based in Canada and United States. Jane E. Mackie's co-authors include Kurt C. Almquist, Susan P.C. Cole, James H. Gerlach, Ebba U. Kurz, Alessandra M.V. Duncan, Alistair Stewart, R G Deeley, Caroline E. Grant, Gerald S. Marks and David R. Hipfner and has published in prestigious journals such as Science, The FASEB Journal and Biochemical Pharmacology.

In The Last Decade

Jane E. Mackie

13 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line

1992 2.5k citations Susan P.C. Cole, James H. Gerlach et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jane E. Mackie Canada	8	2.3k	1.2k	715	462	392	13	2.8k
G J Zaman Netherlands	10	2.1k 0.9×	910 0.7×	805 1.1×	526 1.1×	313 0.8×	10	2.5k
HJ Broxterman Netherlands	19	1.9k 0.9×	1.1k 0.9×	599 0.8×	403 0.9×	285 0.7×	27	2.5k
Marilyn M. Cornwell United States	19	2.5k 1.1×	1.8k 1.5×	501 0.7×	323 0.7×	425 1.1×	24	3.1k
M J Flens Netherlands	17	1.8k 0.8×	873 0.7×	565 0.8×	483 1.0×	233 0.6×	25	2.2k
Ulrike Buchholz Germany	13	2.4k 1.1×	830 0.7×	1.3k 1.8×	545 1.2×	329 0.8×	17	3.0k
Douglas W. Loe Canada	14	2.6k 1.2×	917 0.7×	1.1k 1.6×	549 1.2×	398 1.0×	14	3.0k
Shin-ichi Akiyama Japan	27	1.6k 0.7×	1.2k 1.0×	518 0.7×	325 0.7×	259 0.7×	47	2.5k
Martin G. Belinsky United States	33	2.7k 1.2×	1.5k 1.2×	1.0k 1.4×	777 1.7×	480 1.2×	51	4.2k
R J Scheper Netherlands	17	1.8k 0.8×	834 0.7×	583 0.8×	448 1.0×	262 0.7×	27	2.6k
L. Austin Doyle United States	21	3.8k 1.7×	2.3k 1.9×	1.2k 1.6×	618 1.3×	637 1.6×	39	5.0k

Countries citing papers authored by Jane E. Mackie

Since Specialization

Citations

This map shows the geographic impact of Jane E. Mackie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane E. Mackie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane E. Mackie more than expected).

Fields of papers citing papers by Jane E. Mackie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane E. Mackie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane E. Mackie. The network helps show where Jane E. Mackie may publish in the future.

Co-authorship network of co-authors of Jane E. Mackie

This figure shows the co-authorship network connecting the top 25 collaborators of Jane E. Mackie. A scholar is included among the top collaborators of Jane E. Mackie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane E. Mackie. Jane E. Mackie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Almquist, Kurt C., Douglas W. Loe, David R. Hipfner, et al.. (1995). Characterization of the M(r) 190,000 multidrug resistance protein (MRP) in drug-selected and transfected human tumor cell.. PubMed. 55(1). 102–10. 130 indexed citations

Cole, Susan P.C., James H. Gerlach, Jane E. Mackie, et al.. (1992). Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line. Science. 258(5088). 1650–1654. 2544 indexed citations breakdown →

McCluskey, Stuart A., et al.. (1992). Inactivation of cytochrome P450 and inhibition of ferrochelatase by analogues of 3,5-diethoxycarbonyl-l,4-dihydro-2,4,6-trimethylpyridine with 4-nonyl and 4-dodecyl substituents. Canadian Journal of Physiology and Pharmacology. 70(8). 1069–1074. 15 indexed citations

Riddick, David S., et al.. (1991). Porphyrinogenic effects in chick embryo liver cell culture of chloramphenicol analogues that are mechanism-based inactivators of cytochrome P-450. Canadian Journal of Physiology and Pharmacology. 69(4). 526–530. 2 indexed citations

Mackie, Jane E., Donald W. Back, Joshua W. Hamilton, & Gerald S. Marks. (1991). Elevation of δ-aminolevulinic acid synthase and cytochrome PB1 P450 messenger RNA levels by dihydropyridines, dihydroquinolines, sydnones, and N-ethylprotoporphyrin IX. Biochemical Pharmacology. 42(3). 475–483. 7 indexed citations

Mackie, Jane E., et al.. (1990). Effects of 3-(2-phenylethyl)-4-methylsydnone and related sydnones on heme biosynthesis. Biochemical Pharmacology. 39(11). 1767–1774. 5 indexed citations

Riddick, David S., Jane E. Mackie, Thomas E. Massey, & Gerald S. Marks. (1990). 3,5-Diethoxycarbonyl-2,6-dimethyl-4-ethyl-1,4-dihydropyridine inactivates rat liver cytochrome P-450c, but not its orthologue, rabbit lung form 6. Canadian Journal of Physiology and Pharmacology. 68(3). 370–373. 4 indexed citations

Mackie, Jane E. & Gerald S. Marks. (1989). Synergistic induction of δ-aminolevulinic acid synthase activity by N-ethylprotoporphyrin IX and 3,5-diethoxycarbonyl-1,4-dihydro-2,6-dimethyl-4-isobutylpyridine. Biochemical Pharmacology. 38(13). 2169–2173. 7 indexed citations

Marks, Gerald S., Jane E. Mackie, Stuart A. McCluskey, & David S. Riddick. (1989). Regulation of Heme Biosynthesis in Chick Embryo Liver Cells. Advances in experimental medicine and biology. 271. 123–133. 3 indexed citations

10.

Marks, Gerald S., Stuart A. McCluskey, Jane E. Mackie, David S. Riddick, & C.A. James. (1989). Interaction of chemicals with cytochrome P-450: Implications for the porphyrinogenicity of drugs. Clinical Biochemistry. 22(3). 169–175. 7 indexed citations

11.

Mackie, Jane E., et al.. (1988). 2,2-Dialkyl-1,2-dihydroquinolines: cytochrome P 450 catalyzed N-alkylporphyrin formation, ferrochelatase inhibition, and induction of 5-aminolevulinic acid synthase activity. Chemical Research in Toxicology. 1(4). 208–215. 7 indexed citations

12.

Marks, Gerald S., Stuart A. McCluskey, Jane E. Mackie, David S. Riddick, & C.A. James. (1988). Disruption of hepatic heme biosynthesis after interaction of xenobiotics with cytochrome P‐450. The FASEB Journal. 2(12). 2774–2783. 68 indexed citations

13.

Stormont, James M., Jane E. Mackie, & Colin Davidson. (1961). Increased Concentration of Free Fatty Acids in Liver Disease.. Experimental Biology and Medicine. 106(3). 642–644. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact